This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Apr;14(4):293.

doi: 10.1007/s12603-010-0064-3.

Early Alzheimer's trials: new developments

B Vellas, P S Aisen

PMID: 20305997
DOI: 10.1007/s12603-010-0064-3

Free article

Editorial

Early Alzheimer's trials: new developments

B Vellas et al. J Nutr Health Aging. 2010 Apr.

Free article

. 2010 Apr;14(4):293.

doi: 10.1007/s12603-010-0064-3.

Authors

B Vellas, P S Aisen

PMID: 20305997
DOI: 10.1007/s12603-010-0064-3

No abstract available

PubMed Disclaimer

Similar articles

Antibody drugs for Alzheimer's show glimmers of promise.
Reardon S. Reardon S. Nature. 2015 Jul 30;523(7562):509-10. doi: 10.1038/nature.2015.18031. Nature. 2015. PMID: 26223602 No abstract available.
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
Karran E, Mercken M, De Strooper B. Karran E, et al. Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. doi: 10.1038/nrd3505. Nat Rev Drug Discov. 2011. PMID: 21852788 Review.
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A. Engler H, et al. Brain. 2006 Nov;129(Pt 11):2856-66. doi: 10.1093/brain/awl178. Epub 2006 Jul 19. Brain. 2006. PMID: 16854944
NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost.
Underwood E. Underwood E. Science. 2015 Jul 31;349(6247):464. doi: 10.1126/science.349.6247.464. Science. 2015. PMID: 26228122 No abstract available.
Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer's disease.
Camargo LC, Campos GAA, Galante P, Biolchi AM, Gonçalves JC, Lopes KS, Mortari MR. Camargo LC, et al. Neuropeptides. 2018 Feb;67:79-86. doi: 10.1016/j.npep.2017.11.010. Epub 2017 Nov 28. Neuropeptides. 2018. PMID: 29198480 Review.

See all similar articles

Cited by

Advances in tau-based drug discovery.
Noble W, Pooler AM, Hanger DP. Noble W, et al. Expert Opin Drug Discov. 2011 Aug 1;6(8):797-810. doi: 10.1517/17460441.2011.586690. Expert Opin Drug Discov. 2011. PMID: 22003359 Free PMC article.
Vitamin D supplements: a novel therapeutic approach for Alzheimer patients.
Annweiler C, Karras SN, Anagnostis P, Beauchet O. Annweiler C, et al. Front Pharmacol. 2014 Jan 28;5:6. doi: 10.3389/fphar.2014.00006. eCollection 2014. Front Pharmacol. 2014. PMID: 24478705 Free PMC article. No abstract available.
Brain investigation and brain conceptualization.
Redolfi A, Bosco P, Manset D, Frisoni GB; neuGRID consortium. Redolfi A, et al. Funct Neurol. 2013 Jul-Sep;28(3):175-90. Funct Neurol. 2013. PMID: 24139654 Free PMC article. Review.
Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.
Annweiler C, Beauchet O. Annweiler C, et al. Drugs Aging. 2012 Feb 1;29(2):81-91. doi: 10.2165/11597550-000000000-00000. Drugs Aging. 2012. PMID: 22233455 Review.

References

1. J Nutr Health Aging. 2010 Apr;14(4):312-4 - PubMed
1. J Nutr Health Aging. 2010 Apr;14(4):306-9 - PubMed
1. Ann Neurol. 2006 Mar;59(3):512-9 - PubMed
1. J Nutr Health Aging. 2010 Apr;14(4):294 - PubMed
1. Lancet Neurol. 2010 Jan;9(1):119-28 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Springer
Medical
- MedlinePlus Health Information